You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Board of Directors of Spago Nanomedical has resolved to carry out a rights issue with preferential rights for existing shareholders of up to 61.8 MSEK before issue costs. Four (4) shares in Spago Nanomedical entitle for subscription of five (5) new shares in the Rights Issue at a subscriptionAlready…
Business angels and venture capital companies Stoaf III SciTech, Phase2Phase Biopharma and Partnerinvest Norr are backing Vakona with investments totaling SEK 15 million. “We are absolutely delighted and proud to have attracted this investment. It’s a reward for many years of hard work and tAlready a subscriber Login You have read…
Symcel has secured €3.572 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients. The project runs over 28 months with a consortium of academic and clinical opinion leaders Already a subscriber Login You have read all your…
Elekta recently entered into a partnership with the ESTRO [European Society for Radiotherapy & Oncology] Cancer Foundation (ECF) to contribute – hand in hand with various other partners in academia and industry – to the foundation's mission to ensure that "every patient in Europe will have aAlready a subscriber Login…
